Development
Medtronic plc
MDT
$87.44
$0.440.51%
NYSE
| 01/26/2024 | 10/27/2023 | 07/28/2023 | 04/28/2023 | 01/27/2023 | |
|---|---|---|---|---|---|
| Revenue | 8.09B | 7.98B | 7.70B | 8.55B | 7.73B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.09B | 7.98B | 7.70B | 8.55B | 7.73B |
| Cost of Revenue | 2.77B | 2.75B | 2.61B | 2.95B | 2.66B |
| Gross Profit | 5.32B | 5.24B | 5.09B | 5.60B | 5.06B |
| SG&A Expenses | 2.62B | 2.62B | 2.52B | 4.29B | 2.56B |
| Depreciation & Amortization | 419.00M | 425.00M | 429.00M | -1.28B | 431.00M |
| Other Operating Expenses | 30.00M | -47.00M | 51.00M | 143.00M | 36.00M |
| Total Operating Expenses | 6.54B | 6.45B | 6.28B | 6.74B | 6.37B |
| Operating Income | 1.55B | 1.54B | 1.42B | 1.80B | 1.35B |
| Income Before Tax | 1.47B | 1.31B | 1.20B | 1.55B | 1.37B |
| Income Tax Expenses | 135.00M | 402.00M | 400.00M | 362.00M | 146.00M |
| Earnings from Continuing Operations | 1.34B | 911.00M | 797.00M | 1.19B | 1.23B |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -15.00M | -2.00M | -6.00M | -9.00M | -6.00M |
| Net Income | 1.32B | 909.00M | 791.00M | 1.18B | 1.22B |
| EBIT | 1.55B | 1.54B | 1.42B | 1.80B | 1.35B |
| EBITDA | 2.20B | 2.21B | 2.10B | 2.23B | 2.03B |
| EPS Basic | 0.99 | 0.68 | 0.59 | 0.89 | 0.92 |
| Normalized Basic EPS | 0.79 | 0.72 | 0.67 | 0.92 | 0.70 |
| EPS Diluted | 0.99 | 0.68 | 0.59 | 0.88 | 0.92 |
| Normalized Diluted EPS | 0.78 | 0.72 | 0.67 | 0.92 | 0.70 |
| Average Basic Shares Outstanding | 1.33B | 1.33B | 1.33B | 1.33B | 1.33B |
| Average Diluted Shares Outstanding | 1.33B | 1.33B | 1.33B | 1.33B | 1.33B |
| Dividend Per Share | 0.69 | 0.69 | 0.69 | 0.68 | 0.68 |
| Payout Ratio | 69.36% | 100.99% | 116.06% | 76.76% | 73.98% |